Glenview, IL, United States of America

E Terry Papoutsakis

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 60(Granted Patents)


Company Filing History:

goldMedal1 out of 834,350 
Other
 patents

Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: E Terry Papoutsakis: Innovator in Hematopoietic Cell Research

Introduction

E Terry Papoutsakis is a notable inventor based in Glenview, IL (US). He has made significant contributions to the field of hematopoietic cell research. His innovative work focuses on methods that enhance our understanding of progenitor cells.

Latest Patents

Papoutsakis holds a patent for a method of determining progenitor cell content of a hematopoietic cell culture. The invention provides a method that involves measuring one or more metabolic parameters of the culture, such as oxygen consumption, glucose consumption, and/or lactate production. These measured parameters are then used to determine the content of progenitor cells, which is crucial for advancements in medical research and therapies.

Career Highlights

Throughout his career, Papoutsakis has demonstrated a commitment to advancing scientific knowledge in his field. His work has implications for various applications, particularly in regenerative medicine and cell therapy. He has been recognized for his innovative approaches and contributions to the scientific community.

Collaborations

Papoutsakis has collaborated with esteemed colleagues, including William M Miller and Paul Compton Collins. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation.

Conclusion

E Terry Papoutsakis is a distinguished inventor whose work in hematopoietic cell research has paved the way for new methodologies in understanding progenitor cells. His contributions continue to impact the field significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…